shortage of glp 1 GLP-1 Antagonists Increase Plan Drug Spend - What's Next How FDA Crackdowns Are Affecting

Data are presented as medians (interquartile ranges) or frequencies (%), and Wilcoxon signed-rank tests and Mann-Whitney U tests were used for paired and nonpaired group comparisons, respectively

Background Regular exercise is an effective non-pharmacological therapy for treatment and prevention of cardiovascular diseases (CVD)

Some people who take GLP-1 drugs such as semaglutide and tirzepatide see little to no changes to their weight

Compared with DPP-4 inhibitors, the lower rate of hyperkalemia was consistently observed across individual agents in the SGLT-2 inhibitor (canagliflozin, dapagliflozin, empagliflozin) and GLP-1 receptor agonist (dulaglutide, exenatide, liraglutide, semaglutide) classes